Features, genetics and in vivo importance of lymphocyte mediated natural cytotoxicity. 1978

G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng

UI MeSH Term Description Entries
D007104 Immune Adherence Reaction A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell. Adherence Reaction, Immune,Adherence Reactions, Immune,Immune Adherence Reactions,Reaction, Immune Adherence,Reactions, Immune Adherence
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites

Related Publications

G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng
January 1978, Oncology,
G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng
August 1995, Immunological reviews,
G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng
January 1984, Arthritis and rheumatism,
G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng
June 1987, Pediatric annals,
G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng
January 2002, Annual review of immunology,
G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng
January 1981, Texas reports on biology and medicine,
G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng
April 1977, International journal of cancer,
G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng
January 1985, Annual review of immunology,
G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng
January 1980, Scandinavian journal of immunology,
G G Petrányi, and G Györffy, and M Benczur, and M Varga, and E Gyódi, and K Onody, and G Füst, and I Láng
September 1982, Cellular immunology,
Copied contents to your clipboard!